Operating Lease, Right-of-Use Asset of Coherus Oncology, Inc. from 31 Dec 2018 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Coherus Oncology, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Dec 2024.
  • Coherus Oncology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2024 was $4,518,000, a 24% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Coherus Oncology, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,518,000 -$1,394,000 -24% 31 Dec 2024 8-K 13 Nov 2025
Q4 2023 $5,912,000 +$222,000 +3.9% 31 Dec 2023 8-K 13 Nov 2025
Q4 2022 $5,690,000 -$2,503,000 -31% 31 Dec 2022 10-K 15 Mar 2024 2023 FY
Q4 2021 $8,193,000 -$1,763,000 -18% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q2 2021 $8,900,000 -$2,099,000 -19% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $9,430,000 -$2,097,000 -18% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $9,956,000 -$693,000 -6.5% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $10,470,000 -$663,000 -6% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $10,999,000 +$4,646,000 +73% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $11,527,000 +$4,761,000 +70% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $10,649,000 +$10,649,000 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $11,133,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $6,353,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $6,766,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.